WellCare Health Plans in its $17.3 billion acquisition by Centene Corporation
Bristol-Myers Squibb in its pending $90 billion acquisition of Celgene
Bristol-Myers Squibb on the offer from Taisho Pharmaceutical to purchase the UPSA consumer health business for $1.6 billion
Amcor Ltd. in its pending $6.8 billion acquisition of Bemis Co.
Panavision in its business combination with SIM Video International and Saban Capital Acquisition Corp.
Warburg Pincus in its $775 million sale of the Gordian Group to Fortive Corporation
Barteca Restaurant Group in its $325 million sale to Del Frisco’s Restaurant Group, Inc.
Värde Partners in its acquisition of Credit Shop Inc.
Warburg Pincus in its acquisition of 50% of Cyren Ltd., an Israeli public company dual-listed in Israel and the United States, through a primary PIPE transaction and secondary tender offer
Bristol-Myers Squibb in its sale of its manufacturing facility in Swords, Ireland, to SK Biotek Co., Ltd.
Apax Partners in its acquisition of Kepro
Swift Transportation in its $6 billion stock-for-stock merger with Knight Transportation
Alvarez & Marsal Capital Partners in its sale of Centerra Group
Quinpario Acquisition Corp. 2 in its $2.8 billion combination with SourceHOV, LLC and Novitex Holdings, Inc. to form Exela Technologies Inc.
Mead Johnson Nutrition in its $17.9 billion sale to Reckitt Benckiser Group plc.
Acelity, L.P. Inc., a portfolio company of Apax Partners, in its global refinancing in conjunction with the sale of its LifeCell business to Allergan plc.
Littlejohn & Co. and Anchorage Capital in their sale of Contech Engineered Solutions to Quikrete Holdings
nThrive in its acquisition of Adreima
